Proteasome activation and nNOS down-regulation in neuroblastoma cells expressing a Cu,Zn superoxide dismutase mutant involved in familial ALS

Journal of Neurochemistry

Volumn 85, Issue 5, 2003, Pages 1324-1335

  Aquilano, Katia ^a   Rotilio, Giuseppe ^a   Ciriolo, Maria Rosa ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Carbonyls; Neuronal nitric oxide synthase; Nitric oxide; Proteasome; Reactive oxygen species

Indexed keywords

5,5' DIMETHYL 1 PYRROLINE N OXIDE; ANTIOXIDANT; CALPAIN; COPPER ZINC SUPEROXIDE DISMUTASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEASOME; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMYOTROPHIC LATERAL SCLEROSIS; CELL SURVIVAL; CYCLIC N-OXIDES; CYSTEINE ENDOPEPTIDASES; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; MULTIENZYME COMPLEXES; MUTATION; NEUROBLASTOMA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; OXIDATION-REDUCTION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TUMOR CELLS, CULTURED;

EID: 0037565274     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01783.x     Document Type: Article

References (56)

1. Aksenov M. Y., Tucker H. M., Nair P., Aksenova M. V., Butterfield D. A., Estus S. and Markesbery W. R. (1998) The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J. Mol. Sci. 11, 151-164.
2. Beauchamp C. and Fridovich I. (1971) Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal. Biochem. 44, 276-287.
3. Beckman J. S. (1996) Nitric Oxide: Principle and Actions. Academic Press, San Diego.
4. Bender A. T., Demady D. R. and Osawa Y. (2000) Ubiquitination of neuronal nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 275, 17407-17411.
5. Blomgren K., Kawashima S., Saido T. C., Karlsson J. O., Elmered A. and Hagberg H. (1995) Fodrin degradation and subcellular distribution of calpains after neonatal rat cerebral hypoxic-ischemia. Brain Res. 684, 143-149.
6. Brown L. A., Key B. J. and Lovick T. A. (1999) Bio-imaging of nitric oxide-producing neurones in slices of rat brain using 4,5-diaminofluorescein. J. Neurosci. Methods 92, 101-110.
7. 2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett. 414, 365-368.
8. Chevion M., Berenshtein E. and Stadtman E. R. (2000) Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic. Res. 33, S99-S108.
9. Ciriolo M. R., De Martino A., Lafavia E., Rossi L., Carri M. T. and Rotilio G. (2000) Cu,Zn-superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells. J. Biol. Chem. 275, 5065-5072.
10. Ciriolo M. R., Aquilano K., De Martino A., Carri M. T. and Rotilio G. (2001) Differential role of superoxide and glutathione in S-nitrosoglutathione-mediated apoptosis: a rationale for mild forms of familial amyotrophic lateral sclerosis associated with less active Cu,Zn superoxide dismutase mutants. J. Neurochem. 77, 1433-1443.
11. Cluskey S. and Ramsden D. B. (2001) Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol. Pathol. 54, 386-392.
12. Davies K. J. (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83, 301-310.
13. Dawson T. M. and Snyder S. H. (1994) Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14, 5147-5159.
14. Dawson T. M., Steiner J. P., Dawson V. L., Dinerman J. L., Uhl G. R. and Snyder S. H. (1993) Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. 90, 9808-9812.
15. De Martino G. N. and Slaughter C. A. (1999) The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274, 22123-22126.
16. Ding Q. and Keller J. N. (2001) Proteasome and proteasome inhibition in the central nervous system. Free Radic. Biol. Med. 31, 574-584.
17. Fenteany G. and Schreiber S. L. (1998) Lactacystin, proteasome function and cell death. J. Biol. Chem. 273, 8545-8548.
18. Ferri A., Gabbianelli R., Casciati A., Celsi F., Rotilio G. and Carri M. T. (2001) Oxidative inactivation of calcineurin by Cu,Zn superoxide dismutase G93A, a mutant typical of familial amyotrophic lateral sclerosis. J. Neurochem. 79, 531-538.
19. Finkel T. (2000) Redox-dependent signal transduction. FEBS Lett. 476, 52-54.
20. Floyd R. A. (1999) Antioxidant, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222, 236-245.
21. Fridovich I. (1999) Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? Ann. N. Y. Acad. Sci. 893, 13-18.
22. Fruh K., Gossen M., Wang K., Bujard H., Peterson P. A. and Yang Y. (1994) Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J. 13, 3236-3244.
23. Gafni J. and Ellerby L. M. (2002) Calpain activation in Huntington's disease. J. Neurosci. 22, 4882-4889.
24. Guttmann R. P., Elce J. S., Bell P. D., Isbell J. C. and Johnson G. V. (1997) Oxidation inhibits substrate proteolysis by calpain I but not autolysis. J. Biol. Chem. 272, 2002-2012.
25. Halliwell B. (2002) Hypothesis: proteasomal dysfunction: a primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death. Ann. N. Y. Acad. Sci. 962, 182-194.
26. Halliwell B. and Gutteridge J. M. C. (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Meth. Enzymol. 186, 1-85.
27. Herrlich P. and Bohmer F. D. (2000) Redox regulation of signal transduction in mammalian cells. Biochem. Pharmacol. 59, 35-41.
28. Keller J. N., Hanni K. B. and Markesbery W. R. (2000a) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439.
29. Keller J. N., Hanni K. B. and Markesbery W. R. (2000b) Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech. Ageing Dev. 113, 61-70.
30. Kim Y. M., Bombeck C. A. and Billiar T. R. (1999) Nitric oxide as a bifunctional regulator of apoptosis. Circ. Res. 84, 253-256.
31. Kotsonis P., Frey A., Frohlich L. G., Hofmann H., Reif A., Wink D. A., Feelisch M. and Schmidt H. H. (1999) Autoinhibition of neuronal nitric oxide synthase: distinct effects of reactive nitrogen and oxygen species on enzyme activity. Biochem. J. 340, 745-752.
32. Lainé R. and Ortiz de Montellano P. R. (1998) Neuronal nitric oxide synthase isoforms α and μ are closely related calpain-sensitive proteins. Mol. Pharmacol. 54, 305-312.
33. Lee M., Hyun D., Jenner P. and Hallywell B. (2001) Effect of proteasome inhibition on cellular oxidative damage, antioxidant defence and nitric oxide production. J. Neurochem. 78, 32-41.
34. Leist M. and Nicotera P. (1998) Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239, 183-201.
35. Liu R., Li B., Flanagan S. W., Oberley L. W., Gozal D. and Qiu M. (2002) Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival. J. Neurochem. 80, 488-500.
36. Lopez-Figueroa M. O., Caamano C., Marin R., Guerra B., Alonso R., Morano M. I., Akil H. and Watson S. J. (2001) Characterization of basal nitric oxide production in living cells. Biochim. Biophys. Acta. 1540, 253-264.
37. Lopez Salon M., Morelli L., Castano E. M., Soto E. F. and Pasquini J. M. (2000) Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62, 302-310.
38. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193, 265-275.
39. Lynch G. and Baudry M. (1987) Brain spectrin, calpain and long-term changes in synaptic efficacy. Brain. Res. Bull. 18, 809-815.
40. McNaught K. S. and Jenner P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297, 191-194.
41. Moncada S., Palmer M. J. and Higgs E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142;.
42. Morrison B. M. and Morrison J. H. (1999) Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase: a putative mechanism of degeneration. Brain Res. Brain Res. Rev. 29, 121-135.
43. Musial A. and Eissa N. T. (2001) Inducible nitric oxide synthase is regulated by the proteasome degradation pathway. J. Biol. Chem. 276, 24268-24273.
44. Nixon R. A., Saito K. I., Grynspan F., Griffin W. R., Katayama S., Honda T., Mohan P. S., Shea T. B. and Beerman M. (1994) Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann. N. Y. Acad. Sci. 747, 77-91.
45. Noguchi S., Jianmongkol S., Bender A. T., Kamada Y., Demady D. R. and Osawa Y. J. (2000) Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase. J. Biol. Chem. 275, 2376-2380.
46. Pontremoli S. and Melloni E. (1986) Extralysosomal protein degradation. Annu. Rev. Biochem. 55, 455-481.
47. Reinheckel T., Sitte N., Ullrich O., Knuckelkom U. and Davies K. J. (1998) Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem. J. 335, 637-642.
48. Rigo A., Viglino P. and Rotilio G. (1975) Polarographic determination of superoxide dismutase. Anal. Biochem. 68, 1-8.
49. Roe J. A., Wiedau-Pazos M., Moy V. N., Goto J. L., Gralla E. B. and Valentine J. (2002) In vivo peroxidative activity of FALS-mutant human Cu,Zn SODs expressed yeast. Free Rad. Biol. Med. 32, 169-174.
50. Schmidt H. H. H. W., Kelm M., Feelish M., Stamler J. S. eds (1996) Methods in Nitric Oxide Research, pp. 491-497. John Wiley, New York.
51. Slivka A., Spina M. B. and Cohen G. (1987) Reduced and oxidized glutathione in human and monkey brain. Neurosci. Lett. 74, 112-118.
52. Steinkuhler C., Sapora O., Carri M. T., Nagel W., Marcocci L., Ciriolo M. R., Weser U. and Rotilio G. (1991) Increase of Cu,Zn-superoxide dismutase activity during differentiation of human K562 cells involves activation by copper of a constantly expressed copper-deficient protein. J. Biol. Chem. 266, 24580-24587.
53. Strack P. R., Waxman L. and Fagan J. M. (1996) Activation of the multicatalytic endopeptidase by oxidants. Effects on the enzyme structure. Biochemistry 35, 7142-7149.
54. Thannickal V. J. and Fanburg B. L. (2000) Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, 1005-1028.
55. Wiedau-Pazos M., Goto J. J., Rabizadeh S., Gralla E. B., Roe J. A., Lee M. K., Valentine J. S. and Bredesen D. E. (1996) Altered reactivity of superoxide dismutase in familial amyotrophyc lateral sclerosis. Science 271, 515-518.
56. Yim M. B., Kang J., Yim H., Kwak H., Chock P. B. and Stadtman E. R. (1996) A gain of function of amyotrophic lateral sclerosis associated Cu,Zn superoxide dismutase mutant, enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. 93, 5709-5714.